LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 326 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 1.44 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $4,000 | 0.0% | 33 | 0.0% | 0.00% | – |
Q4 2018 | $4,000 | -55.6% | 33 | 0.0% | 0.00% | – |
Q3 2018 | $9,000 | +28.6% | 33 | 0.0% | 0.00% | – |
Q2 2018 | $7,000 | +40.0% | 33 | 0.0% | 0.00% | – |
Q1 2018 | $5,000 | 0.0% | 33 | 0.0% | 0.00% | – |
Q4 2017 | $5,000 | +25.0% | 33 | 0.0% | 0.00% | – |
Q3 2017 | $4,000 | – | 33 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
KNOTT DAVID M | 353,041 | $25,673,000 | 16.20% |
Stonepine Capital Management, LLC | 160,919 | $11,702,000 | 12.38% |
VILLERE ST DENIS J & CO LLC | 635,758 | $46,232,000 | 3.94% |
CARDINAL CAPITAL MANAGEMENT LLC /CT | 982,049 | $71,415,000 | 3.51% |
Elk Creek Partners, LLC | 246,251 | $17,907,000 | 3.08% |
Tygh Capital Management, Inc. | 151,792 | $11,038,000 | 2.47% |
Roubaix Capital, LLC | 20,034 | $1,457,000 | 2.21% |
Conestoga Capital Advisors, LLC | 648,603 | $47,166,000 | 1.38% |
RICE HALL JAMES & ASSOCIATES, LLC | 338,376 | $24,607,000 | 1.38% |
Ikarian Capital, LLC | 200,000 | $14,544,000 | 1.09% |